We have recently identified that rat organic anion transporters, polypeptide2 (oatp2) and oatp3, both of which transport thyroid hormones. However, in humans the molecular organization of the organic anion transporters has diverged, and the responsible molecule for thyroid hormone transport has not been clarified, except for human liver-specific transporter (LST-1) identified by us. In this study we isolated and characterized a novel human organic anion transporter, OATP-E from human brain. The isolated complementary DNA encodes a polypeptide of 722 amino acids with 12 transmembrane domains. A rat counterpart, oatp-E, was also identified. Homology analysis and the phylogenetic tree analysis revealed that OATP-E/oatp-E is a subfamily of the organic anion transporter. Human OATP-E transported 3,3Ј,5-triiodo-L-thyronine (K m , 0.9 M), thyronine, and rT 3 in a Na ϩ -independent manner. Although the clone was isolated from the brain, OATP-E messenger RNA was abundantly expressed in various peripheral tissues. The rat counterpart, oatp-E, also transported 3,3Ј,5-triiodo-L-thyronine. In addition, in this study we revealed that human OATP, which is exclusively expressed in the brain, transported 3,3Ј,5-triiodo-L-thyronine (K m , 6.5 M), T 4 (K m , 8.0 M), and rT 3 . These data suggest that in humans, several different molecules are involved in transporting thyroid hormone: OATP in the brain, LST-1 in the liver, and OATP-E in peripheral tissues. (Endocrinology
T HYROID HORMONE plays an essential role in the mammalian central nervous system and peripheral tissues. Hypothyroidism causes serious damages to neural cells and leads to mental retardation (1) (2) (3) . The action of thyroid hormone is mainly mediated through the deiodination of T 4 into T 3 , followed by the binding of T 3 to a specific nuclear receptor (4, 5) . Before reaching intracellular targets, thyroid hormone must cross the plasma membrane. It has been widely accepted that this process is mediated by saturable, stereospecific, and energy-dependent transporter (6 -10) . Recently, we have isolated two Na ϩ -independent rat organic anion transporters, polypeptide2 (oatp2) and oatp3, which transport thyroid hormones (11) . The tissue distribution patterns of oatp2 and oatp3 are widely expressed; the oatp2 messenger RNA (mRNA) is mainly distributed in the brain, retina, and liver, and the oatp3 mRNA in the retina, liver, and kidney.
In humans, two organic anion transporters have been reported: liver-specific organic anion transporter (LST-1) (12) and human OATP (13) . Compared with rat oatps, the expression of these isolated organic anion transporters is much organ specific. LST-1 is exclusively expressed in the liver, and OATP in the brain (12) . In addition, although LST-1 transports thyroid hormones (12) , no molecules transporting thyroid hormone have been identified in other tissues.
Here, we report the isolation and pharmacological characterization of human and rat novel organic anion transporters, OATP-E/oatp-E, which transport thyroid hormone in various peripheral tissues. Combined with our data demonstrating that human OATP transports thyroid hormone in the brain, these results suggest that thyroid hormone transport is mediated by different molecules with distinct expression patterns in humans.
Materials and Methods Materials
T 3 , T 4 , rT 3 , taurocholate, sulfobromophthalein (BSP), PGD 2 
Isolation of human and rat complementary DNA (cDNA)
The GenBank database dbEST was searched for all known mammalian oatp family and PG transporters. As a result, a clone that had weak to moderate similarity to both the oatp family and the PG transporters was identified (GenBank accession no. H85940). A human hippocampus cDNA library was constructed in a ZAPII vector (14) . Independent clones (5 ϫ 10 5 ) were screened with the EST clone under high stringency (12) . In a series of screenings, two clones were isolated, and the clone that had the largest insert (pH8) was chosen for further analysis. The sequences were determined using ABI PRISM 377 DNA sequencer (Perkin-Elmer Corp., Foster City, CA). A rat retina cDNA library (5 ϫ 10 5 independent clones) was also screened with the same EST fragment.
Homology analysis
The hydropathy profile analysis was performed according to the method reported by Kyte and Doolittle (15) . Multiple sequence alignments of amino acid sequences were carried out using CLUSTAL W (16). The phylogenetic tree was described by TreeView (17) .
Northern blot analysis
Human multiple tissue Northern blots containing 2 g polyadenylated RNA were purchased (CLONTECH Laboratories, Inc., Palo Alto, CA). The coding region of pH8 (EcoRI-EcoRI, 2125 bp) was used as a probe. Filters were hybridized with the 32 P-labeled fragment in a buffer containing 50% formamide, 5 ϫ SSC (standard saline citrate), 5 ϫ Denhardt's solution, and 1% SDS at 42 C overnight; washed in 0.1 ϫ SSC and 0.1% SDS at 65 C for 1 h; and exposed to film at Ϫ80 C overnight (11, 12, 14) . Human ␤-actin was also used to qualify the quality of the mRNA.
RT-PCR
The tissue distribution of human OATP-E was further characterized by RT-PCR. The primers used are located in the exon 1 (forward) and exon 2 of human OATP-E genome (GenBank accession no. AL357033; forward, 5Ј-CGGCCGGGCCCTCGAGAC-3Ј; reverse, 5Ј-GCAGGGCACGTCCT-GACA-3Ј) to avoid nonspecific amplification from the genomic DNA. A human multiple tissue cDNA panel (CLONTECH Laboratories, Inc.) was used as a template. As a control, glyceraldehyde-3-phosphate dehydrogenase primers were used (forward, 5Ј-TCCACCACCCTGTTGCTGTAG-3Ј; reverse, 5Ј-GACCACAGTCCATGCCATCACT-3Ј). PCR amplification was performed using a hot start amplification protocol with LA Taq (Takara) combined with the Taq Start Antibody (CLONTECH Laboratories, Inc.) according to the following schedule: 94 C for 1 min for the first cycle, then 94 C for 0.5 min and 67 C for 4 min for 30 cycles. PCR products were transferred to a nylon membrane and hybridized with the radiolabeled OATP-E full cDNA fragment.
Expression in Xenopus oocytes
The capped RNA of pH8 was transcribed in vitro. Xenopus laevis oocytes were prepared as described previously (11, 12, 14) . Defolliculated oocytes were microinjected with 10 ng transcribed RNA and cultured for 72 h in modified Barth's medium at 18 C. The uptake of radiolabeled chemicals was measured at room temperature in a medium containing 100 mm NaCl, 2 mm KCl, 1 mm CaCl 2 , 1 mm MgCl 2 , and 10 mm HEPES, pH 7.5. After washing with the same buffer, each oocyte was dissolved in 500 l 10% SDS, and the radioactivity was counted with 4 ml scintillation fluid in a liquid scintillation counter (Packard, Downers Grove, IL). Water-injected oocytes were used as controls. 
Results

Isolation and structural analysis of OATP-E/oatp-E
The isolated cDNA encodes a novel organic anion transporter, human organic anion transporting polypeptide (OATP)-E, which consists of 722 amino acids (M r , 77,189) with 132 bases and 218 bp of 5Ј-and 3Ј-untranslated regions, respectively. The 5Ј-sequence preceding the start codon contained stop codons in all three frames. Hydrophobicity analysis of the predicted OATP-E suggested the presence of 12 transmembrane domains (Fig. 1A) . In human OATP-E, there are two putative N-glycosylation sites in the predicted extracellular loops, and one potential phosphorylation site for cAMP-dependent protein kinase and seven potential phosphorylation sites for protein kinase C in the cytosolic portions (18, 19) (Fig. 1A) . The sequence homology analysis revealed a moderate sequence similarity to the oatp family, human LST-1/rat rlst-1, and the PG transporter. The overall amino acid sequence identities of OATP-E were 31.2% to human PG transporter (20) , 31.0% to rat PG transporter (21), 30.6% to oatp1 (22), 28.6% to oatp2 (11, 23), 32.2% to oatp3 (11), 29.5% to OAT-K1 (24), 32.4% to OAT-K2 (25), 29.8% to human OATP (13), 30.8% to human LST-1 (12), 23.2% to rat rlst-1 (26), 28.4% to rat oatp4, which is thought to be a complete form of rlst-1 (27) , and 29.5% to rat moat1 (28) . We also isolated the rat counterpart oatp-E from rat retina. The overall homology between rat oatp-E and human OATP-E was 72.6% at the amino acid level, and the transmembrane domains and their surrounding area were highly conserved (Fig. 1A) . Phylogenetic tree analysis showed that human OATP-E and rat oatp-E can be localized separately from LST-1/rlst-1, the PG transporter, and the oatp family (Fig. 1B) . These data suggest that OATP-E and oatp-E are supposed to be new members of the organic anion transporter family.
OATP-E-mediated uptake of thyroid hormone
Based on the structural similarities to organic anion transporters, we surmised that human OATP-E can transport organic anions. Among the compounds tested, the oocytes injected with human OATP-E complementary RNA (cRNA) significantly transported T 3 and taurocholate (Table 1) , both of which are preferable substrates for the oatp family and LST-1/rlst-1.
The OATP-E-cRNA injected oocytes increased uptake of Table 1 ). These OATP-E-mediated uptakes were saturable with increasing substrate concentrations. The apparent K m values for T 3 and taurocholate determined by three independent experiments were 0.9 Ϯ 0.4 and 14.9 Ϯ 3.3 m, respectively (Fig. 2) . This OATP-E-mediated uptake was not inhibited by replacing the extracellular Na ϩ with choline (data not shown). OATP-E also transported T 4 and rT 3 weakly, but significantly (Table 1 and Fig. 7 ). In addition, we examined the transport activity of rat oatp-E. The oocytes injected with transcribed rat oatp-E RNA also transported T 3 and taurocholate (Fig. 3) . On the other hand, although PGE 2 was slightly transported, other eicosanoids (PGD 2 , PGE 1 , and PGF 2␣ ) and PAH were not transported (Table 1 ). These data indicate that OATP-E/oatp-E encode a subfamily of the organic anion transporter that transports thyroid hormone.
Inhibition of OATP-E-mediated substrate uptake by various compounds
To investigate the substrate specificity, the effects of 0.5, 5, and 50 m of various compounds on OATP-E-mediated 
Northern blot analysis and RT-PCR
Northern blot analysis of human OATP-E showed two bands (one major band at 3.0 kilonucleotides and another minor band at 5.0 kilonucleotides) in heart, placenta, lung, liver, skeletal muscle, kidney, and pancreas (Fig. 5A) . The two different sized bands of the OATP-E mRNA are probably derived from the same gene, because both bands were observed under high stringency filter-washing conditions, although we cannot exclude the possibility of alternative splicing. To further examine the tissue distribution of human OATP-E, RT-PCR was performed (Fig. 5B) .
To further exclude the possibility of genomic DNA amplification, we searched databases and identified the genomic organization. According to the sequence (GenBank Accession No. AL357033), the human OATP-E mRNA is derived from 12 exons (Fig. 6) . On the basis of the organization, we designed a PCR primer set flanking between exon 1 and exon 2 (Fig. 6) . As a result, RT-PCR generated bands in brain, spleen, thymus, prostate, testis, and small intestine in addition to the organ detected by Northern blot analysis (Fig. 5B, upper panel) . The bands were further identified by hybridization with human OATP-E radiolabeled probe (Fig. 5B, middle panel) .
Transport of thyroid hormone by human OATP
Because of its exclusive expression of mRNA in the brain, we further examined whether human OATP transports thyroid hormone. Oocytes injected with OATP cRNA significantly transported 7-and 3-fold higher amounts of Fig. 7 ). This OATPmediated uptake was linear for at least 60 min and was independent of extracellular Na ϩ (data not shown). This OATP-mediated transport of thyroid hormone was saturable with increasing substrate concentrations. The apparent K m values for T 3 and T 4 uptake determined by three independent experiments were 6.5 Ϯ 2.5 and 8.0 Ϯ 1.7 m, respectively (Fig. 8) .
Discussion
In the present study we revealed that several molecules are involved in transporting thyroid hormone in humans, and furthermore, that the responsible molecules and their distribution patterns are different in humans and rats.
In human liver, carrier-mediated transport of thyroid hormone have been predicted. Our previous data revealed that LST-1, which is exclusively expressed in the human liver, transported T 4 and T 3 in a Na ϩ -independent manner (12). The pharmacological characterization of LST-1-mediated thyroid hormone uptake is consistent with the previous data reported in human liver (29, 30) . This is the first report identifying a human molecule that transports thyroid hormone. However, thyroid hormone transport systems have been distributed in various organs [reviewed by Partridge (1)]. What kinds of molecules are involved in thyroid hor- mone transport in other tissues? To answer this, we performed further molecular screening and pharmacological characterization. As a result, we isolated a novel organic anion transporter subfamily, OATP-E/oatp-E. The present results demonstrate that human and rat OATP-E/oatp-E both transport thyroid hormone in a Na ϩ -independent manner. The apparent K m of human OATP-E for T 3 was 0.9 Ϯ 0.4 m. The pharmacological characterization revealed that nonlabeled T 3 , T 4 , and taurocholate showed a definite inhibitory effect on OATP-E-mediated [
125 I]T 3 uptake. OATP-E-mediated [
3 H]taurocholate uptake was also inhibited by taurocholate, BSP, and T 3 . In contrast, PGD 2 , PGE 1 , PGE 2 , PGF 2␣ , and PAH showed no or little inhibitory effect. According to these substrate specificities, we designated the isolated clone as a subfamily of OATP according to its substrate specificity rather than its amino acid sequence homology. These data suggest that OATP-E is the candidate molecule for thyroid hormone transport in humans.
In this study we also revealed that human OATP, which is exclusively expressed in the brain (12), transports thyroid hormones. To date, there are a few reports about thyroid hormone uptake in the central nervous system (31) (32) (33) (34) (35) . The reported K m for thyroid hormone uptake varies from the nanomolar level in mouse neuroblastoma cells (31) to the micromolar level in rat glia cells (32) . The K m for OATP obtained in this study is in the same range of values for cultured cerebrocortical neurons and rat glial cells (32) . We conclude from these data that in humans different transporting molecules are involved in transporting thyroid hormone in the brain (OATP), liver (LST-1), and peripheral tissues (OATP-E).
In rats we previously reported that rat oatp2 and oatp3 transport thyroid hormones (11) . Subsequently, Friesema et al. reported that rat oatp1 also transports thyroid hormone (36) . In contrast to that in humans, the tissue distribution of rat molecules responsible for thyroid hormone transport is completely different. These transporters are distributed in several organs compared with human LST-1 and OATP. Rat oatp1 is expressed in brain, liver, and kidney; oatp2 in brain, retina, and liver; and oatp3 in retina, liver, and kidney. These Significance between water-injected and cRNA-injected oocytes was determined by unpaired t test (*, P Ͻ 0.05; **, P Ͻ 0.01).
data further indicate the species difference of the molecules responsible for thyroid hormone transport between humans and rats.
The discovery of OATP-E/oatp-E will also explain the existence of thyroid hormone transport systems in other tissues at the molecular level. OATP-E is slightly expressed in the small intestine. Bile acids secreted by the liver enter the intestine, which are absorbed in large part by the ileum, and return to the liver by way of the portal vein (37, 38) . In addition, the existence of an enterohepatic circulation of thyroid hormone in the rat has been well established (39 -43) . Because OATP-E and LST-1 transport both thyroid hormone and taurocholate, it is suggested that OATP-E and LST-1 may be involved in the transport of bile acids and thyroid hormone in this circulation. OATP-E mRNA is also expressed in the kidney. Most T 4 secreted from the thyroid gland is deiodinated in peripheral tissues. The liver and kidney are the major peripheral organs producing T 3 from T 4 (44) . Thus, the expression of OATP-E mRNA in the kidney suggests the essential role in transporting thyroid hormone from the circulation to the deiodination sites in the kidney, like oatp3 in rats (11) . Furthermore, OATP-E mRNA is expressed in skeletal muscle. It is well known that T 3 enters skeletal muscle cells by an active transport system (8, 45, 46) . Thus, again, OATP-E may transport thyroid hormone by a Na ϩ -independent process in the peripheral tissues.
Individuals with Refetoff's syndrome, which is characterized by resistance to thyroid hormone, exhibit reduced clinical and biochemical activities of thyroid hormone relative to the circulating hormone level (47) . It has been well known that the molecular basis of the syndrome is the abnormality of the nuclear thyroid hormone receptor TR-␤. However, among these patients, other functional defects have been postulated. One possible mechanism is reduced hormone availability to tissues due to impaired thyroid hormone entry into neural cells (47) . Thus, our finding might provide a clue for identifying one of the genetic pathogeneses of the disease.
Studies using isolated rat hepatocytes suggested multiple transporters for uptake of T 4 , T 3 , and rT 3 . A role of extracellular Na ϩ in thyroid hormone uptake has been also suggested. Treatment of hepatocytes with Na ϩ /K ϩ -adenosine triphosphatase inhibitor or replacement of extracellular Na ϩ results in a marked decrease in thyroid hormone uptake, suggesting that the uptake is Na ϩ dependent (48) . Recently, rat Na ϩ /taurocholate cotransporting polypeptide has been reported to transport thyroid hormone (37) , although its mRNA is only expressed in the liver. Further molecular characterization and identification are necessary to clarify this Na ϩ -dependent thyroid hormone uptake fraction in vivo.
In conclusion, candidate molecules responsible for thyroid hormone transport have been identified and have been found to be different in rats and humans. Our findings should aid in understanding the delivery of thyroid hormone to tissue in humans. 
